PEGylation strategies for enhanced nanoparticle delivery to tumor-associated immune cells.
- DOI
- 10.1002/btm2.70098
- Published
- 2026 May
- Container
- Bioengineering & translational medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/btm2.70098,
title = {PEGylation strategies for enhanced nanoparticle delivery to tumor-associated immune cells.},
author = {Cahn D and Pal S and Stern A and Patel NL and Gower T and Kapnick SM and Jewell CM and Duncan GA and Wolf MT},
year = {2026},
journal = {Bioengineering \& translational medicine},
doi = {10.1002/btm2.70098},
url = {https://doi.org/10.1002/btm2.70098}
}RIS
TY - JOUR TI - PEGylation strategies for enhanced nanoparticle delivery to tumor-associated immune cells. AU - Cahn D AU - Pal S AU - Stern A AU - Patel NL AU - Gower T AU - Kapnick SM AU - Jewell CM AU - Duncan GA AU - Wolf MT PY - 2026 JO - Bioengineering & translational medicine DO - 10.1002/btm2.70098 UR - https://doi.org/10.1002/btm2.70098 ER -
APA
D, C., S, P., A, S., NL, P., T, G., SM, K., CM, J., GA, D., & MT, W. (2026). PEGylation strategies for enhanced nanoparticle delivery to tumor-associated immune cells.. Bioengineering & translational medicine. https://doi.org/10.1002/btm2.70098
Source records
- pubmed · retrieved 2026-09-27T01:10:13.645Z